Maximizing Weight Loss vs. Protecting the Heart: The Paradox of Modern Anti-Obesity Drugs
As global demand for anti-obesity medications surges, a fierce pharmaceutical race is underway to develop next-generation successors to blockbusters...
Search results for "patient safety"
AI Cancer Gene Analysis and 810 Billion-Won Tech Export Lead South Korea's Top 30 Health Care R&D Achievements
The Ministry of Health and Welfare and the Korea Health Industry Development Institute announced on the 8th that they have selected the "2026 Health...
Seconds Count: Three Essential Strategies to Prevent Child Drowning During Water Play
Data from the U.S. Centers for Disease Control and Prevention reveals that between 4,000 and 5,000 people die by...
Why Eating Around the Mold on Your Food Is a Dangerous Gamble
“Ugh, what a waste. It’s just a tiny bit, so I should probably just eat it.”When I was young, my grandmother would...
Get Second and Third Opinions Before Spine Surgery, Urges Renowned Scoliosis Surgeon Kim Yong-jung
Dr. Kim Yong-jung, Director of the Spinal Deformity Center at Seoul Bumin Hospital, has performed approximately 2,400...
Navigating Stem Cell Hype: Can Any Hospital Truly Offer Regenerative Medicine?
Consider a patient in their 60s whose knee cartilage has completely worn down, making every step up a flight of stairs...
United Therapeutics Acquires Thymmune, Betting 460 Billion Won on Thymus Cell Therapy
The race to develop regenerative cell therapies for an ultra-rare disease that leaves patients born without a...
Considering Wegovy for Weight Loss? South Korea's Drug Safety Ministry Warns It Is Not for Everyone
South Korea’s Ministry of Food and Drug Safety issued a strong warning on July 8 against the misuse and abuse of GLP-1...
ABL Bio’s Stomach Cancer Drug Shows Promise in Once 'Untreatable' Patients
South Korean platform biotech company ABL Bio announced that development remains firmly on track despite investor...
MediPost Begins Pivotal U.S. Phase 3 Trial for Regenerative Knee Therapy Cartistem
South Korean biotechnology company MediPost has entered full-scale Phase 3 clinical testing in the United States for...